Skip to content

Agios Pharmaceuticals AGIO Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin90%+2.5pp88.3%-0.3pp87.2%-2.2pp88.2%-1.1pp87.5%-2.4pp
Operating margin-720%+469pp-873.9%+293pp-1,061.8%+176pp-1,129.1%+165pp-1,188.9%+148pp
Net margin-639.8%-764%
Returns
Return on equity-32.8%-30.2%
Return on invested capital-38.5%+2.8pp-35.4%+1.3pp-35.6%-0.7pp-46.7%+4.0pp-41.3%+4.7pp
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio14.2×-4.3×11.5×-0.4×13.8×+4.8×14.5×+4.4×18.5×+5.7×
Leverage
Debt-to-equity0.0×0.0×0.0×-0.1×-0.1×
Per Share
Book value per share$18.87-26.1%$20.58-22.7%$22.09-20.6%$23.64+103%$25.52+93.4%
Valuation
Market capitalization$1.98B+18.1%$1.59B-15.3%$2.33B-7.7%$1.94B-20.9%$1.68B+2.2%
Price / sales30×-15.3×29.4×-22.0×52.1×-24.8×47.4×-30.8×45.3×-10.6×
Price / book1.8×+0.6×1.3×+0.1×1.8×+0.3×1.4×-2.3×1.1×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Agios Pharmaceuticals's profit margins?
Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.
Where do Agios Pharmaceuticals's ratios come from?
Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.